• ablelab
    (Owner)
    • Last updated 28.07.2021
    • 0 comments, 134 views, 0 likes
1 review found.
  • 15.04.2020
    Summary:
    A comprehensive and critical review of the clinical literature indicated that the consumption of GlcN at usual doses was well tolerated by normal, diabetic, and ‘pre-diabetic’ subjects. Thus, based on the overall weight of scientific evidence, there currently appears to be no reason to restrict the ... Read complete review